Patrick Guertin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

04.08.21 -- Regulatory, Legislative Actions Set The Tone For Biosimilars In 2021   On this episode of the Business of Biotech, Nevan Charles Elam, J.D., founder of Rezolute Bio, shares the company's rationale for pursuing congenital hyperinsulinism and diabetic macular edema therapeutics by leveraging monoclonal antibodies and discusses the company's approach to process development and manufacturing. Listen now and subscribe so you never miss an episode. Featured Editorial By Philip Chen, Kayleigh McGlynn, and Jenny Shmuel, Fish & Richardson P.C. This artic...

12.10.20 -- Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19     Nanoform Finland Plc (Nanoform), an innovative nanoparticle medicine enabling company, will be featured in an upcoming Advancements episode broadcasting via CNBC on Saturday, December 12, at 2:30 p.m. (ET). Viewers will learn how Nanoform’s award-winning CESS® nanoparticle engineering technology can potentially double the number of drug candidates progressing into clinic. Featured Editorial By Ronald A. Rader and Eric S. Langer, BioPlan Associates, Inc. Despite the morbid...